AgendaWebsite ApplicationSpeakersAttendeesOverviewDinner Interview WSGR website


Registration for this event is now closed.

The Medical Device Dinner on June 11th is sold out. If you wish to attend the Medical Device Conference
on June 12th, onsite registration will be available.

Conference Agenda

Wednesday, June 11, 2014
Sharon Heights Golf and Country Club
2900 Sand Hill Road
Menlo Park, CA

6:00 – 9:00 p.m.

Medical Device Dinner Interview Geoffrey S. MarthaClick here to view video
Senior Vice President, Strategy and Business Development
Join David Cassak in a conversation with Geoffrey S. Martha about Medtronic's US and International Strategies.  Learn about recent transactions completed by Medtronic and how your company may fit into Medtronic's initiatives and focus for the future.

Thursday, June 12, 2014

The Intercontinental Hotel
888 Howard Street
San Francisco, CA

7:00 – 8:00 a.m.

Conference Registration and Continental Breakfast

8:00 – 8:10 a.m.

Welcome, Casey McGlynn, Partner, Wilson Sonsini Goodrich & Rosati Click here to view video

8:10 – 9:10 a.m.

Venture Investing Today (Grand Ballroom, 3rd Floor) Click here to view video
Getting a new medical device company funded is harder today. An ever-shrinking pool of venture capital interested in early stage life science investing, larger capital requirements due to prolonged regulatory timelines, and increasingly complex and stringent reimbursement processes, and an increasing emphasis on global markets and the need for true sales traction to garner the attention of potential corporate acquirers have all become the hallmarks of the current financing environment. How are venture investors adapting their financing strategies and business models to accommodate these realities and position themselves for long-term success? Join a panel of venture capital investors and to explore their approaches to investing in these changing times.


Donna Petkanics, Partner, Wilson Sonsini Goodrich & Rosati


Leslie Bottorff, Managing Director, Healthcare, GE Ventures

Imran Eba, Partner, Action Potential Venture Capital

Marc Galletti, Partner, Longitude Capital

Ross Jaffe, M.D., Partner, Versant Ventures

9:10 – 9:30 a.m.


9:30 – 10:30 a.m.

Breakout Session 1

Understanding Corporate Investors and Buyers (Union Square, 3rd Floor) Click here to play audio
Join David Cassak for a discussion with several large Medtech consolidators as they review recent acquisitions, investments and corporate partnering transactions.  Learn about their areas of interest, how they evaluate companies and their appetite for early versus late stage deals. Join a discussion about the differing structures involved including debt versus equity, buyout options, rights of first refusal, and negotiation.


David Cassak, Managing Partner, Innovation in Medtech LLC


Susan Morano, VP Bus Dev, Global Surgery Group, Johnson & Johnson

Gwen Watanabe, Vice President, Business Development and Technical Resources, Teleflex Incorporated

Brad Vale, Ph.D., Head of Johnson & Johnson Development Corporation,
Johnson & Johnson

Funding Strategies for Entrepreneurs (Grand Ballroom, 3rd Floor) Click here to view video
Finding capital today is difficult no matter what the stage of the company. This panel of entrepreneurs and CEOs will share their experiences in the search for capital. Learn about the types of deals that are getting done today and the requirements that need to be met to be seriously considered for investment. This panel will discuss the methods and strategies used by leading companies to find capital today and the changing areas of investor interest.


Casey McGlynn, Partner, Wilson Sonsini Goodrich & Rosati


Daniel Burnett, M.D., President & CEO, TheraNova

Laura Dietch, MBA, MSc, President & CEO, BioTrace Medical, Inc.

Beverly Huss, M.S., President & CEO, Qool Therapeutics

Doug Wall, Managing Director, Volcano Capital

Managing Your Patent Portfolio (Telegraph Hill, 4th Floor) Click here to play audio
Developing the world's best medical technology should be enough, but you're also expected to both patent it and defend it within a shrinking budget. Join a panel of medical technology experts, including a successful serial entrepreneur and experienced in-house and outside patent counsel as they discuss how to build value into an IP portfolio while managing costs in today's challenging Medtech environment. The panel will discuss successful strategies for preparing and prosecuting patent applications inside and outside the US as well as facing the patents of competitors in the most cost-effective ways possible.


Michael Rosato, Partner, Wilson Sonsini Goodrich & Rosati


Amir Belson, M.D., Founder, Neoguide Systems


Cindy Lynch, Vice President of Intellectual Property, Elixir Medical Corporation


Doug Portnow, Associate, Wilson Sonsini Goodrich & Rosati

10:30 – 10:50 a.m.


10:50 – 11:50 a.m

Breakout Session 2

From Volume to Value—What Payors and Providers Want
(Grand Ballroom, 3rd Floor)
Click here to view video
Today more than ever, Medtech companies must demonstrate how their devices will both improve care and save the healthcare system money.  The Affordable Care Act has shifted the economic risks of care from the payers to the providers.  Additionally the consolidation of providers is creating much greater purchasing power.  These changes are forcing Medtech companies to find new ways to define clinical and economic benefit.  Join this group of Payers and Providers to learn what attributes your products need to be successful in this new world.


Lisa Suennen M.D., Managing Partner, Venture Valkyrie Consulting, LLC


Swati Awsare, M.D., Northern California Medical Director, Aetna, Inc.

Paul Heidenreich M.D., M.S., Professor of Medicine and Vice-Chair, Stanford University School of Medicine

Sam Ho, M.D., Chief Medical Officer, UnitedHealthcare

Alan Russell, Ph.D., Executive Vice President and CIO, Allegheny Health Network

Collaborations Between Japan and Silicon Valley (Telegraph Hill, 4th Floor) Click here to play audio
There is growing interest from Japan to invest in and collaborate with US Medtech companies, incubators and venture funds, many of which are located in Silicon Valley.  For the first time in many years the major Japanese companies are focusing on reenergizing their Medtech businesses.  This represents a major opportunity for Silicon Valley startups to seek investments from and partnerships with Japanese businesses.  Join this panel of Japanese experts who will help explain the reasons driving Japan's renewed interest in advanced medical technologies and the resulting possibilities for collaboration.


Jack Moorman, Principal, LeVaunt, LLC


Masazumi ("Masa") Ishii, Managing Director, AZCA, Inc.

Kenneth McDonnell, General Manager, Business Development, Terumo Medical Corporation

Hajime Oshita, President and CEO, MedVenture Partners, Inc.

European Market Access – Is it dead or is there still an opportunity? (Union Square, 3rd Floor) Click here to view video
The increased regulatory hurdle for CE-marking and the barriers for reimbursement creates a challenging environment to introduce new technologies in Europe. Some may argue that Europe is no longer a feasible first market for entry. In this session we will review the current reality, discuss areas of opportunity and what the formula for success could be.


Mattias Kyhlstedt, CEO and Founder, Synergus AB and Synergus Corp. 


Anna Sohlberg, Director Strategy and Market Access for Europe & MEA, CVRx Inc.

11:50 a.m. – 12:10 p.m.


12:10 – 1:10 p.m.

Breakout Session 3

International Funding Strategies (Grand Ballroom, 3rd Floor) Click here to view video
Join a panel of experienced executives who have successfully raised capital in Asia and the European Union.  Meet international investors and advisors who can help you fund your company or help you to establish a business in Asia or the European Union.  Learn how these transactions are structured and the reasons that draw international capital to the US and US entrepreneurs to Europe, China, Singapore, Korea, and Japan.


Elton Satusky, Partner, Wilson Sonsini Goodrich & Rosati


Allan Johnston Ph.D., Co-Founder and Managing Director, Synergy Ventures

Eitan Konstantino Ph.D., CEO, QT Vascular Ltd.

Trevor Moody, General Partner, TM Strategic Advisors, LLC

Hank Plain, General Partner, Lightstone Ventures

Lean LaunchPad – A Better Startup Strategy (Union Square, 3rd Floor) Click here to play audio
In today's tough funding climate, innovation in science and technology is not enough. The Lean LaunchPad approach to building Medtech startups focuses on innovative business models. The Key is getting founders "out of the building" to solicit direct feedback from potential customers and key stakeholders. This "Lean" approach shifts startup thinking from writing business plans and execution to the early testing of critical hypotheses about the business, allowing adjustments or pivots on little or no capital.  Join Allan May and several CEO's as they discuss the Lean LaunchPad Concept and the things that entrepreneurs need to have in place before they start to look for money.


Allan May, Chairman, Life Science Angels


Hobart Harris M.P.H., M.D., Chief of General Surgery, UCSF Medical Center

Charvi Shetty, Founder, KNOX Medical Diagnostics

Management Compensation! (Telegraph Hill, 4th Floor) Click here to play audio
Let's talk about executive compensation for the Medtech executive.  Join a group of compensation experts as they look at recent trends and emerging best practices in compensation.  Participate in a discussion of current salary, stock and bonus structures for management.  Learn about the structure and pitfalls associated with carve out plans and innovative ways to provide management teams compensation for successful exits.


Scott McCall, Partner, Wilson Sonsini Goodrich & Rosati


Roger Anderson, Managing Partner, BioQuest LLC

Jody Thelander, President, J. Thelander Consulting

1:10 – 2:40 p.m.

LUNCH – A Conversation with Ron Dollens (InterContinental Ballroom, 5th Floor) & (Overflow Room - Sutter, 5th Floor)
In its decade from start-up to exit, Guidant Corp. created arguably more value than any other medical device company in history. Join David Cassak in conversation with Ron Dollens the former CEO of Guidant as they look back a decade to the $27 Billion sale of Guidant Corporation and explore what made Guidant such a successful company.


David Cassak, Managing Partner, Innovation in Medtech


Ron Dollens, Former President and Chief Executive Officer, Guidant Corporation

2:40 – 3:40 p.m.

Breakout Session 4

Medtech – A Time of Change (Grand Ballroom, 3rd Floor)
Using Guidant as a case study, the panel will explore the factors behind Guidant’s success -- factors that generally were at play during the Medtech industry‘s flourishing in the 1990s and early 2000s -- before turning to the present.  Drawing on the insights of several industry leaders, we’ll contrast the different dynamics driving our industry today.  What do these changing factors tell us about the companies and products we’re building and the strategies and tactics critical to success in today’s medical device world.  Join us as a group of luminaries discuss the challenges and opportunities for Medtech today reflected through the prism of Guidant’s story.


David Cassak, Managing Partner, Innovation in Medtech


Ron Dollens, Former President and Chief Executive Officer, Guidant Corporation


John Capek, Ph.D., Executive Vice President Medical Devices, Abbott Laboratories


Jay Graf, Venture Partner, New Enterprise Associates


Robbie Huffines, Vice Chairman of Investment Banking,
JPMorgan Chase & Co.


Dana Mead, Partner, Kleiner Perkins Caufield & Byers

Developing Exit Opportunities (Union Square, 3rd Floor) Click here to play audio
Medtech M&A activity increased last year and this increase continues today.  Although the IPO market for Biotech businesses has been robust, underwriters have only recently begun to actively pitch IPOs to mature Medtech companies. From this vantage point we enter 2014 with hope for both the continued vibrancy of the M&A market and the emergence of a fragile but expanding IPO market for high quality Medtech companies. With this as a background, our panel will explore current investor appetite for Medtech IPOs, the status of the emerging window for public offerings and the likely minimum requirements to be considered an attractive Medtech IPO candidate. The panel will also discuss several of the trends emerging from recent Medtech M&A transactions.


Philip Oettinger, Partner, Wilson Sonsini Goodrich & Rosati


Drew Hoffman, Former President & CEO, Nanostim, Inc.

Todd Pope, President & CEO, TransEnterix, Inc.

Jon Salveson, Managing Director, Piper Jaffray & Co.

Incubators and Accelerators (Telegraph Hill, 4th Floor) Click here to play audio
There is an increasing number of incubators and accelerators developing new Medtech products today.  We will explore several of these businesses; look at the kinds of companies they are starting and the process they go through in identifying new opportunities and in obtaining the funding needed to bring these ideas to reality. 


Scott Murano, Partner, Wilson Sonsini Goodrich & Rosati


Hanson Gifford, Managing Member, The Foundry, LLC


Howard Levin, M.D., Co-Founder, Coridea, Inc.

Kerry Pope, Executive Director, Fogarty Institute for Innovation

Ted Ridgway, Co-Founder, Chief Investment Officer & Chief Financial Officer, Launchpad Digital Health

Medtech Compliance Workshop (Nob Hill, 4th Floor) Click here to play audio
In recent years there has been significant regulatory changes affecting the medical device industry.   These changes make it more important than ever that each company establish an overall compliance program.  Join a panel of experts who will discuss best practices today including adoption of a code of a business conduct, appointment of a compliance officer, managing physician relationships and compensation, understanding the Foreign Corrupt Practices Act and Medicare Anti-Kickback Laws.  In the past several years there have been an increasing number of investigations and suits against small Medtech companies for failure to comply with these complex requirements.  Don't get caught short.


David Hoffmeister, Partner, Wilson Sonsini Goodrich & Rosati


Adam Toronto, Director, Commercial Compliance, Compliance
Implementation Services

3:40 – 4:00 p.m.


4:00– 5:00 p.m.

Medtech Innovator 2014 with $175,000 in Prizes! (Grand Ballroom, 3rd Floor) Click here to view video
Your votes will determine the company that will be crowned MedTech Innovator of 2014! Ten semi-finalist companies have been selected out of 267 submissions to vie for $175,000 in prizes. Each of the semi-finalists has submitted a 1-minute pitch video that will be played for the audience. A panel of active medical device investors will select four finalist companies to make presentations and give feedback to each of the companies that present. The audience will then vote using their smart phones or tablets. The first place winner will receive a $125,000 grand prize, and the second place winner will receive $25,000. The first place winner will also get a presentation slot and complimentary full access registration to the AdvaMed 2014 conference. RCT Ventures produced the competition and contributed $100,000 towards the cash prizes. Several of the Johnson & Johnson Family of Companies contributed $50,000 in cash prizes and entry to the Janssen Labs community, valued at $25,000.

To read detailed information about the 10 semi-finalists, go to:


James Dreher, Managing Partner, Option 3


Chris Martin, President Medical Devices & Chief Financial Officer, RCT Ventures


Ned Scheetz, Managing Director and Founder, Aphelion Capital


Brad Vale Ph.D., Head of Johnson & Johnson Development Corporation, Johnson & Johnson Development Corporation

Producer & Master
of Ceremonies:

Paul Grand, Managing Director, RCT Ventures

Meet the Contestents:

AUM Cardiovascular, Inc.

AventaMed Ltd.

BeckerSmith Medical, Inc.

BrainStem Biometrics


CystoSure / Emmy Medical

Fibralign Corporation


LensGen, Inc.

TaMI (Tampa Medical Innovations)

5:00 – 6:30 p.m.

Venture Wine Tasting (Pacific Terrace, 4th floor)
Join Wilson Sonsini Goodrich & Rosati for wine tasting after the conference. We will be sampling wines from various wineries, with venture capitalists serving as your sommeliers for the event. This is your chance to try some great wine and learn a little bit more about what each of our local venture firms is looking for in its next deal. It's a great pairing—wine with a venture capital twist.